 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/05/2026 |
$30.71 |
$32.67 |
$29.75 |
$32.55 |
836.80K | | 01/06/2026 |
$32.22 |
$35.74 |
$32.22 |
$35.22 |
1.19M | | 01/07/2026 |
$35.84 |
$37.34 |
$35.09 |
$35.17 |
982.40K | | 01/08/2026 |
$34.08 |
$34.84 |
$33.22 |
$33.68 |
629.70K | | 01/09/2026 |
$33.91 |
$34.34 |
$32.46 |
$32.85 |
673.50K |
|
|
| Stoke Therapeutics, Inc. is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with ribonucleic acid (RNA)-based medicines. Co., through its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach, is engaged in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. TANGO aims to restore missing proteins by increasing or stoking protein output from healthy genes, thus compensating for the non-functioning copy of the gene. | |
|
Stoke Therapeutics (STOK) has the following price history information. Looking back at STOK historical stock prices for the last five trading days, on January 05, 2026, STOK opened at $30.71, traded as high as $32.67 and as low as $29.75, and closed at $32.55. Trading volume was a total of 836.80K shares. On January 06, 2026, STOK opened at $32.22, traded as high as $35.74 and as low as $32.22, and closed at $35.22. Trading volume was a total of 1.19M shares. On January 07, 2026, STOK opened at $35.84, traded as high as $37.34 and as low as $35.09, and closed at $35.17. Trading volume was a total of 982.40K shares. On January 08, 2026, STOK opened at $34.08, traded as high as $34.84 and as low as $33.22, and closed at $33.68. Trading volume was a total of 629.70K shares. On January 09, 2026, STOK opened at $33.91, traded as high as $34.34 and as low as $32.46, and closed at $32.85. Trading volume was a total of 673.50K shares.
STOK Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Stoke Therapeutics shares, starting with a $10,000 purchase of STOK, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/20/2019 |
|
| End date: |
01/09/2026 |
|
| Start price/share: |
$26.00 |
|
| End price/share: |
$32.85 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
26.35% |
|
| Average Annual Total Return: |
3.63% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$12,636.02 |
|
| Years: |
6.56 |
|
|
|
| Date |
Close |
| 01/05/2026 | $32.55 | | 01/06/2026 | $35.22 | | 01/07/2026 | $35.17 | | 01/08/2026 | $33.68 | | 01/09/2026 | $32.85 |
|
|
Free STOK Email Alerts:
